Cargando…
miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer
Pancreatic adenocarcinoma (PDAC) is a highly fatal disease worldwide. MicroRNAs (miRNAs) could regulate the protein-coding RNAs related to tumor growth, invasion, and immune evasion. Therefore, the investigation of novel miRNAs may be helpful in the development of more effective therapies for PDAC....
Autores principales: | Xi, Qing, Chen, Ying, Yang, Guang-Ze, Zhang, Jie-You, Zhang, Li-Juan, Guo, Xiang-Dong, Zhao, Jing-Yi, Xue, Zhen-Yi, Li, Yan, Zhang, Rongxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267029/ https://www.ncbi.nlm.nih.gov/pubmed/32536914 http://dx.doi.org/10.3389/fimmu.2020.00890 |
Ejemplares similares
-
Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity
por: Xi, Qing, et al.
Publicado: (2020) -
Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer
por: Yu, Lan, et al.
Publicado: (2021) -
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
por: Zhang, Wenting, et al.
Publicado: (2020) -
MiR-128-2 inhibits common lymphoid progenitors from developing into progenitor B cells
por: Yang, Yi, et al.
Publicado: (2016) -
CD47 expression and CD163(+) macrophages correlated with prognosis of pancreatic neuroendocrine tumor
por: Imam, Rami, et al.
Publicado: (2021)